Selective inhibition of multiple cytokines: A novel therapeutic strategy for immune-mediated diseases

被引：1
|
作者：
Azimi, N. [1 ]
Massoud, R. [2 ]
Jacobson, S. [2 ]
Tagaya, Y. [3 ]
机构：
[1] Bioniz, Lake Forest, IL USA
[2] NIH, Bethesda, MD 20892 USA
[3] Inst Human Virol, Baltimore, MD USA
来源：
CYTOKINE | 2012年 / 59卷 / 03期
关键词：
D O I：
10.1016/j.cyto.2012.06.269
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：573 / 573
页数：1
相关论文
共 50 条
  • [21] Apoptosis in immune-mediated diseases
    Sankari, S. Leena
    Babu, N. Aravindha
    Rajesh, E.
    Kasthuri, M.
    JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2015, 7 (05): : S200 - S202
  • [22] Immune-mediated liver diseases
    Strassburg, C. P.
    Trautwein, C.
    GASTROENTEROLOGE, 2018, 13 (03): : 170 - 170
  • [23] Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions
    Mendes-Bastos, Pedro
    Brasileiro, Ana
    Kolkhir, Pavel
    Frischbutter, Stefan
    Scheffel, Joerg
    Monino-Romero, Sherezade
    Maurer, Marcus
    ALLERGY, 2022, 77 (08) : 2355 - 2366
  • [24] JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
    Schwartz, Daniella M.
    Kanno, Yuka
    Villarino, Alejandro
    Ward, Michael
    Gadina, Massimo
    O'Shea, John J.
    NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (12) : 843 - 862
  • [25] JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
    Daniella M. Schwartz
    Yuka Kanno
    Alejandro Villarino
    Michael Ward
    Massimo Gadina
    John J. O'Shea
    Nature Reviews Drug Discovery, 2017, 16 : 843 - 862
  • [26] Lactoferrin as a Therapeutic to Decrease Immune-Mediated Tissue Damage in Infectious Diseases
    Welsh, K. J.
    Hwang, S.
    Boyd, S.
    Kruzel, M. L.
    Hunter, R. L.
    Actor, J. K.
    ANNALS OF EMERGENCY MEDICINE, 2011, 58 (04) : S239 - S240
  • [27] Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies
    Bayry, Jagadeesh
    Radstake, Timothy R.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (04) : 297 - 299
  • [28] Interleukin-21 as a new therapeutic target for immune-mediated diseases
    Monteleone, Giovanni
    Pallone, Francesco
    Macdonald, Thomas T.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (08) : 441 - 447
  • [29] Semaphorin3A: A potential therapeutic tool in immune-mediated diseases
    Vadasz, Zahava
    Toubi, Elias
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (01) : 58 - 61
  • [30] Tumour necrosis factor a as a therapeutic target for immune-mediated inflammatory diseases
    Taylor, PC
    Williams, RO
    Feldmann, M
    CURRENT OPINION IN BIOTECHNOLOGY, 2004, 15 (06) : 557 - 563
12345